Pantogam active - description of the drug, instructions for use, reviews

Write a review

Reviews: 0

Manufacturers: TsNKB FSUE (Russia), PIK-PHARMA PRO LLC (Russia)

Active ingredients

• Not indicated. See instructions

Disease class

• Schizophrenia
• Neurotic disorder, unspecified
• Mental retardation, unspecified
• Specific developmental disorders of speech and language
• Specific developmental disorders of learning skills
• Specific developmental disorders of motor function
• Impaired activity and attention
• Tics unspecified
• Enuresis of inorganic nature
• Stuttering [stammering]
• Huntington's disease
• Parkinson's disease
• Other extrapyramidal and movement disorders
• Myoclonus
• Extrapyramidal and movement disorder, unspecified
• Epilepsy, unspecified
• Vascular cerebrovascular syndromes in cerebrovascular diseases (I60-I67*)
• Cerebral palsy
• Cerebral atherosclerosis
• Cerebrovascular disease, unspecified
• Brain disorder in newborn, unspecified
• Excessive activity
• Consequences of intracranial injury
• Antipsychotic and neuroleptic drugs
• Other types of malnutrition
• Neurogenic bladder weakness, not elsewhere classified

Clinical and pharmacological group

• Not indicated. See instructions

Pharmacological action

• Nootropic
• Anticonvulsant

Pharmacological group

• Nootropics

Analogues of the drug according to ATC codes:

VINPOTROPIL GLYCINE CALCIUM HOPANTHENATE COGITUM COMBITROPIL CORTEXIN CORTEXIN MINISEM NOOCLERIN NOOPEPT OMARON PANTOGAM PANTOGAM PANTOCALCIN PIRACESIN PIRACETAM + CINNARIZIN SEMAX PHESAM PHENOTROPIL CEREBROLYSATE CEREBRUS CEREBROLYSIN OLYSATE CYTOFLAVIN All

Interaction with other pharmaceuticals

When prescribing Pantogam active, you should remember that the medicine:

• Extends the effect of barbiturates on the body.
• Strengthens the anticonvulsant effect of medications taken.
• Prevents the development of adverse reactions during treatment with Neuroleptics, Carbamazepine, Phenobarbital.
• Potentiates the therapeutic effect of local anesthetics (procaine).

When used simultaneously with etidronic acid and glycine, the effect of taking the drug is enhanced.

Release form, composition and packaging

Hard gelatin capsules, size No. 1, yellow; the contents of the capsules are white or white powder with a yellowish tint.

Excipients: microcrystalline cellulose - 13.98 mg, magnesium stearate - 1.02 mg.

Composition of the capsule shell: gelatin, glycerol (glycerin), nipagin (methyl parahydroxybenzoate), nipazole (propyl parahydroxybenzoate), sodium lauryl sulfate, purified water, titanium dioxide, yellow iron oxide.

10 pieces. — contour cell packaging (6) — cardboard packs. 15 pcs. — contour cell packaging (4) — cardboard packs. 60 pcs. — polymer jars (1) — cardboard packs.

Hard gelatin capsules, size No. 0, white; the contents of the capsules are white or white powder with a yellowish tint.

Excipients: microcrystalline cellulose - 20.97 mg, magnesium stearate - 1.53 mg.

Capsule shell composition: gelatin, glycerol (glycerin), nipagin (methyl parahydroxybenzoate), nipazole (propyl parahydroxybenzoate), sodium lauryl sulfate, purified water, titanium dioxide.

10 pieces. — contour cell packaging (3) — cardboard packs. 10 pcs. — contour cell packaging (6) — cardboard packs. 15 pcs. — contour cell packaging (2) — cardboard packs. 15 pcs. — contour cell packaging (4) — cardboard packs. 30 pcs. — polymer cans (1) — cardboard packs. 50 pcs. — polymer jars (1) — cardboard packs.

Instructions for use and dosage (adults, elderly, during pregnancy and lactation, children)

Pantogam Active is taken orally a third of an hour after eating breakfast and lunch twice a day. It is preferable to use in the morning and before bed. Take 1-4 capsules 200 mg. The maximum daily dosage is 12 capsules.

Take 300 mg capsules up to three times a day. The maximum number of capsules per day is 8 pieces. The duration of therapy is from one month to four. Sometimes the course can be extended to six months or even a year. After 3 months, you can do another course of treatment.

Pantogam Active is prohibited for use in children under 18 years of age. It is also prohibited to take during pregnancy and lactation. Or stop breastfeeding for the duration of treatment.

Approved for use in older age groups. The dosage is the same as for adults.

pharmachologic effect

The action of Pantogam active is associated with the presence of gamma-aminobutyric acid in its structure, which directly affects the GABAB receptor-channel complex. Pantogam active is a racemic mixture of equal amounts of the R-form of hopantenic acid and its S-isomer. The presence of the isomer improves the transport and interaction of the drug with the GABA receptor. Pantogam active has a more pronounced nootropic and anticonvulsant effect than first-generation hopantenic acid preparations.

Pantogam active increases the brain's resistance to hypoxia and the effects of toxic substances, stimulates anabolic processes in neurons, and combines a moderate sedative effect with a mild stimulating effect. It has antiasthenic and mild anti-anxiety effects. Reduces motor excitability, streamlines behavior. Activates mental activity and performance. Causes inhibition of the pathologically increased bladder reflex and detrusor tone.

Side effects

The use of Pantogam syrup, as well as tablets, is often accompanied by unwanted reactions. If they occur, you should stop taking the drug and visit the doctor who prescribed it. The side effects listed below are ranked according to frequency of occurrence, ranging from very common to very rare:

• The immune system. Various allergic manifestations: skin rashes like urticaria, inflammation of the nasal mucosa, accompanied by swelling, congestion, serous secretion, conjunctivitis.
• Mental disorders. Sleep disorders, in isolated cases drowsiness is observed.
• CNS. Headache, noise or buzzing in the head, dizziness.
• Digestive system. Nausea, pain in the upper abdomen.

It is worth noting that undesirable effects may not appear immediately; their occurrence depends on the individual characteristics of the body.

Indications

• cognitive impairment in organic brain lesions (incl.
• consequences of neuroinfections and traumatic brain injuries) and neurotic disorders;
• cerebrovascular insufficiency,
• caused by atherosclerotic changes in cerebral vessels;
• extrapyramidal hyperkinesis (myoclonus-epilepsy,
• Huntington's chorea,
• hepatolenticular degeneration,
• Parkinson's disease and others),
• as well as for the treatment of extrapyramidal syndrome,
• caused by taking antipsychotics;
• for epilepsy together with anticonvulsants;
• psycho-emotional overload,
• decreased mental and physical performance,
• to improve concentration and memory;
• neurogenic urinary disorders (pollakiuria,
• imperative urges,
• urge urinary incontinence,
• enuresis);
• for schizophrenia in complex therapy.

Pantogam asset

Active substance:

D,L-hopantenic acid

Pharmgroup:

Nootropics

Average price in pharmacies